| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,783,433,954 |
|
|
|
Indirect Value
|
$6,661,333 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,790,095,287 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -0.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2022-06-09 |
4 |
OE |
$0.00 |
$0 |
I/I |
81,025 |
411,044 |
0 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,346,434 |
171,879,226 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-19 |
4 |
S |
$0.53 |
$506,685 |
D/D |
(956,009) |
5,605,414 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-20 |
4 |
S |
$0.53 |
$26,500 |
D/D |
(50,000) |
5,555,414 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-18 |
4 |
S |
$0.56 |
$152,252 |
D/D |
(271,879) |
6,561,423 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-13 |
4 |
S |
$0.59 |
$707,959 |
D/D |
(1,199,930) |
6,833,302 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-12 |
4 |
S |
$0.61 |
$386,725 |
D/D |
(633,975) |
8,033,232 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-11 |
4 |
S |
$0.63 |
$327,664 |
D/D |
(520,102) |
8,667,207 |
0 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-08-16 |
4 |
B |
$0.97 |
$92,003,727 |
D/D |
94,849,203 |
162,532,792 |
2.81 |
% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-05-30 |
4 |
B |
$1.05 |
$2,081,815 |
I/I |
1,982,681 |
1,982,681 |
2.25 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-05-30 |
4/A |
B |
$1.05 |
$2,005,160 |
I/I |
1,909,676 |
1,909,676 |
2.25 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
B |
$1.05 |
$395,314,374 |
D/D |
376,489,880 |
552,354,161 |
2.81 |
% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-10-10 |
4 |
A |
$1.18 |
$100,000 |
D/D |
84,746 |
5,159,310 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2009-07-31 |
4 |
OE |
$1.28 |
$170,691 |
I/I |
133,352 |
649,112 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2009-07-31 |
4 |
OE |
$1.28 |
$6,086,234 |
D/D |
4,754,870 |
9,829,434 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-05 |
4 |
A |
$1.38 |
$655,467 |
D/D |
474,976 |
4,403,365 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-07 |
4 |
B |
$1.40 |
$31,394 |
D/D |
22,431 |
8,443,961 |
2.37 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-21 |
4 |
B |
$1.60 |
$265,667 |
D/D |
166,042 |
4,997,299 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-22 |
4 |
B |
$1.60 |
$1,920 |
D/D |
1,200 |
4,998,499 |
3.84 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-10 |
4 |
B |
$1.60 |
$697,789 |
D/D |
436,500 |
8,880,461 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-19 |
4 |
B |
$1.62 |
$7,525 |
D/D |
4,648 |
8,032,275 |
2.37 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-06 |
4 |
A |
$1.63 |
$278,782 |
D/D |
171,032 |
4,574,397 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-09 |
4 |
A |
$1.64 |
$197,525 |
D/D |
120,442 |
4,694,839 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-11 |
4 |
B |
$1.65 |
$505,010 |
D/D |
306,848 |
9,187,309 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-27 |
4 |
B |
$1.68 |
$129,963 |
D/D |
77,585 |
8,421,530 |
2.45 |
- |
|
318 Records found
|
|
Page 4 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
